99% Savings - Buy Just @1 Rs X
Rosuvas F 5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. The alternative uses of Rosuvas F 5 Tablet have also been explained below.
The right dosage of Rosuvas F 5 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Rosuvas F 5 Tablet are Nausea or vomiting, Headache, Constipation. While these are the most often observed Rosuvas F 5 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Rosuvas F 5 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Rosuvas F 5 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Rosuvas F 5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rosuvas F 5 Tablet related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Rosuvas F 5 Tablet since this can cause severe adverse effects.
Besides this, Rosuvas F 5 Tablet may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Rosuvas F 5 Tablet is not safe while driving, and is not addiction.
Rosuvas F 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rosuvas F 5 Tablet safe for pregnant women?
Rosuvas F can have harmful effects in pregnant women. If you experience any discomfort after using Rosuvas F, then discontinue the use and take your doctor's advice.
Is the use of Rosuvas F 5 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Rosuvas F. If you see any side effects, stop taking Rosuvas F immediately and talk to your doctor. Take Rosuvas F again, only after your doctor's advice.
What is the effect of Rosuvas F 5 Tablet on the Kidneys?
Rosuvas F rarely harms the kidneys.
What is the effect of Rosuvas F 5 Tablet on the Liver?
Side effects of Rosuvas F rarely affect the liver.
What is the effect of Rosuvas F 5 Tablet on the Heart?
Rosuvas F can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Rosuvas F 5 Tablet unless your doctor advises you to do so -
Is this Rosuvas F 5 Tablet habit forming or addictive?
No, there is no any evidence that Rosuvas F 5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Rosuvas F 5 Tablet can make you feel drowsy.
Is it safe?
Yes, but consume Rosuvas F 5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Rosuvas F 5 Tablet is not used to treat mental disorders.
Interaction between Food and Rosuvas F 5 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Rosuvas F 5 Tablet together with food.
Interaction between Alcohol and Rosuvas F 5 Tablet
Information about the interaction of Rosuvas F 5 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650